NeueHealth Top Management

NeueHealth Management Team Effectiveness

The company has return on total asset (ROA) of (0.0196) % which means that it has lost $0.0196 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.8326) %, meaning that it created substantial loss on money invested by shareholders. NeueHealth's management efficiency ratios could be used to measure how well NeueHealth manages its routine affairs as well as how well it operates its assets and liabilities. The market capitalization of NeueHealth is USD60.94 Million. Over half of NeueHealth's outstanding shares are owned by institutional investors. These institutional investors are typically referred to as corporate investors that shop for positions in a given instrument to benefit from reduced trade commissions. Note, that even with negative profits, if the true value of the firm is larger than the current market value, you may still be able to generate positive returns on investment in this company. Some institutional investors establish a significant position in stocks such as NeueHealth in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of NeueHealth, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.

NeueHealth Workforce Comparison

The company has Profit Margin (PM) of (0.09) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of 0.07 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.07.

NeueHealth Insider Trading

NeueHealth Notable Stakeholders

String symbol = request.getParameter("s");

The success or failure of an entity such as NeueHealth often depends on how effective the management is. NeueHealth management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of NeueHealth management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the NeueHealth management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.

Please note, the presentation of NeueHealth's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, NeueHealth's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of NeueHealth's management manipulating its earnings.

Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in private. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.

If you are still planning to invest in NeueHealth check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the NeueHealth's history and understand the potential risks before investing.